The Groundbreaking Acr-Luc Knock-In Mouse Model from Hokkaido University

In a pioneering advancement from Hokkaido University in Japan, researchers have developed the world's first Acr-Luc knock-in mouse model, allowing scientists to track male fertility dynamics in real time without invasive procedures. This glowing sperm mouse model expresses a luciferase reporter gene fused to the acrosin (Acr) promoter, specific to germ cells during spermatogenesis. When administered luciferin, a substrate, these cells emit bioluminescent light detectable via in vivo imaging systems (IVIS), providing a non-invasive window into spermatogenesis progression.

Led by Associate Professor Hisanori Fukunaga from the Faculty of Health Sciences, the team collaborated with Professor Hiroki Shirato at Hokkaido University's Graduate School of Medicine, Associate Professor Haruhiko Miyata from Osaka University's Research Institute for Microbial Diseases, and Professor Kevin M. Prise from Queen's University Belfast. Published in MedComm on January 4, 2026 (DOI: 10.1002/mco2.70568), this innovation addresses longstanding challenges in reproductive research.

The model's stability—maintaining consistent luminescence for over a year—enables longitudinal studies in the same animal, revolutionizing how we understand fertility fluctuations. This is particularly vital in Japan, where the total fertility rate hovers around 1.3, exacerbated by rising male infertility contributing to 10-15% of couples facing reproductive challenges.

Japan's Male Infertility Landscape and Global Context

Male infertility affects approximately half of the 15% of couples worldwide struggling with conception, with Japan mirroring this trend amid its demographic crisis. Globally, male infertility prevalence reached 56.5 million cases in 2019, underscoring the need for better diagnostic and toxicity assessment tools. In Japan, factors like environmental exposures, aging, and cancer treatments compound the issue, making advanced mouse models essential for preclinical insights.

Traditional assessments rely on endpoint analyses—mating trials, histological exams, and sperm counts—requiring numerous animals and failing to capture recovery dynamics. The Acr-Luc model shifts this paradigm, aligning with the 3Rs (Replacement, Reduction, Refinement) in animal research and OECD/ICH guidelines for reproductive toxicity (S5(R3)).

Hokkaido University's contribution positions Japanese academia at the forefront, fostering interdisciplinary ties in health sciences, medicine, and microbiology.

Engineering the Glowing Sperm: From Gene Targeting to Bioluminescence

The core innovation lies in CRISPR/Cas9-mediated knock-in at the Acr locus, a protease gene active in round spermatids during meiosis. The Luciferase (from Gaussia princeps) fuses seamlessly, ensuring light emission mirrors germ cell numbers without disrupting fertility—homozygous mice remain viable and fertile.

1. Gene Insertion: Homology-directed repair inserts Luc under Acr control.
2. Luciferin Administration: Intraperitoneal injection (150 mg/kg) substrates oxidation, producing light at 480 nm.
3. Imaging: IVIS Spectrum CT acquires photon flux (p/s/cm²/sr), quantifying spermatogenesis quantitatively.

Bioluminescence intensity correlates linearly with germ cell counts (R² > 0.95), validated against flow cytometry and histology. This precision enables detecting subtle changes invisible to conventional methods.

Radiation Experiments: Tracking Decline and Recovery In Vivo

The team exposed mice to X-rays (0, 5, 10 Gy), monitoring bioluminescence weekly for 12+ weeks. At 5 Gy, signals dropped 90% by week 4 (spermatogonial arrest), recovering 80% by week 12, confirming reversible azoospermia. 10 Gy caused permanent ablation, no recovery observed—mirroring clinical radiotherapy effects.

Statistical significance (ANOVA, p<0.001) and low intra-individual variability (CV <10%) highlight reliability. Unlike dissection-based assays, this captures temporal dynamics, e.g., distinguishing transient vs. permanent damage.

Quote from Dr. Fukunaga: “Our goal was not just to create a visually striking model, but to establish a rigorous, ethical, and reproducible framework for evaluating male reproductive safety.”

Advantages Over Traditional Reproductive Toxicity Testing

Conventional protocols (e.g., OECD 443) demand 50-100 males/group, endpoint sacrifices, and uncertain fertility correlations. The Acr-Luc model slashes numbers by 70-80%, enables chronic dosing, and integrates with imaging for multi-parameter analysis (e.g., combining with MRI).

• Non-invasive: Repeated measures without stress.
• Quantitative: Photon flux as proxy for germ cells.
• Longitudinal: Tracks recovery, critical for reversibility claims.
• Cost-effective: Reduces breeding/histology needs.

Validated against busulfan (chemo) and environmental toxins, it complements organoid cultures and zebrafish screens. For Japanese pharma, this accelerates ICH-compliant safety data.

Implications for Pharmaceutical Development and Oncofertility

In drug discovery, early toxicity flagging prevents late-stage failures—male repro tox halts 10-20% candidates. This model streamlines screening, aiding Japan's biotech sector amid global male infertility market projected at $6.4B by 2034.

For cancer survivors, it models post-chemo/radiation fertility restoration, informing sperm banking and regenerative therapies. Hokkaido's platform could personalize oncofertility protocols.

External resource: Full paper at MedComm DOI.

Environmental Monitoring and Public Health Applications

Endocrine disruptors (plastics, pesticides) link to declining sperm counts (50% drop since 1970s globally). The model tracks chronic low-dose effects, vital for Japan's pollution hotspots. Longitudinal data reveals cumulative impacts, supporting policy like REACH regulations.

In Hokkaido's context, industrial emissions testing could safeguard fisheries-dependent communities.

Japan's Leadership in Reproductive Science Innovations

Building on iPS cell pioneers like Kyoto's Shinya Yamanaka, Hokkaido extends stem cell expertise to repro tox. Funded by JST FOREST (JPMJFR211E) and JSPS, it exemplifies Japan's $10B+ R&D investment in life sciences.

Osaka's Miyata contributes flagellar expertise, enhancing model robustness.

Future Directions: Toward Human Translation

While mouse-specific, Acr orthologs exist in humans; luciferase reporters could adapt to primates. Integration with AI for signal prediction and multi-omics promises precision medicine. Challenges: optimizing luciferin delivery, scaling for high-throughput.

Dr. Fukunaga envisions: “Turning unexpected visual phenomena into quantitative tools.” Near-term: validate with ICH toxins; long-term: human fertility diagnostics.

External: Hokkaido news here; JST release.

Photo by Jeongmuk Kang on Unsplash

Career Opportunities in Japan's Reproductive Research

This breakthrough highlights demand for experts in genetic engineering, imaging, and toxico-genomics. Hokkaido and Osaka seek postdocs, faculty in repro health. Platforms like AcademicJobs.com higher-ed-jobs list roles in /research-jobs and /higher-ed-jobs/postdoc.

Japan's universities offer competitive salaries (~¥6-10M), grants via JSPS. Explore higher-ed-career-advice for tips.

• Postdoc in Microbial Diseases (Osaka Univ)
• Imaging Specialist (Hokkaido Health Sciences)
• Toxicity Researcher (JST-funded)

Japan's academic ecosystem thrives on international talent—check Japan university jobs.